Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
folliculin | 0.537 | 0.885 | 0.79 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.947 | 8 | 0 | 1989 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.986 | 1 | 0 | 1989 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 7 | 0 | 1990 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 0.963 | 3 | 0 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 2 | 0 | 1990 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1990 | 2019 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.946 | 1 | 0 | 1990 | 2019 | ||||||||
|
ornithine decarboxylase 1 | 0.510 | 0.731 | 0.17 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1990 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.400 | None | 0.979 | 11 | 0 | 1991 | 2019 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
disease | 0.400 | None | 0.885 | 1 | 0 | 1991 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.991 | 2 | 0 | 1992 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.700 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.800 | strong | 0.973 | 3 | 0 | 1993 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.800 | strong | 0.971 | 1 | 0 | 1993 | 2020 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.400 | None | 0.895 | 1 | 0 | 1993 | 2014 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.800 | strong | 0.966 | 0 | 0 | 1993 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.979 | 6 | 0 | 1994 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.400 | None | 0.978 | 1 | 0 | 1994 | 2020 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1994 | 2017 | |||||||||
|
NME/NM23 nucleoside diphosphate kinase 2 | 0.573 | 0.731 | 8.8E-09 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1995 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.500 | None | 0.971 | 1 | 0 | 1995 | 2020 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.891 | 1 | 0 | 1995 | 2019 |